Piramal Pharma's stock, after reaching record highs, experienced profit-taking but is showing signs of a bullish comeback. Experts suggest buying the stock, citing its rebound from the 50-day EMA and strong trading volume, with a potential target of Rs 280-286 in the coming weeks.
